Authors
Latest:
Safety, Outcomes of Early Versus Late ERCP in Liver Transplant RecipientsPatients who underwent ERCP ≤ 30 days post-transplant had greater rates of early post-procedure bleeding but similar rates of technical and clinical success compared to late ERCP.
Latest:
Take-Home Messages for the Management of Crohn’s DiseaseExperts in gastroenterology share advice for the treatment of patients of Crohn’s disease.
Latest:
Prospective Advancements and Final Thoughts on the Treatment of FMExperts conclude their discussion emphasizing the importance of integrative care and how providers can improve outcomes for their patients with fibromyalgia (FM).
Latest:
Key Takeaways and Prospective Treatment AdvancesDavid Hudesman, MD, Maia Kayal, MD, Miguel Regueiro, MD, Anita Afzali, MD, and Millie Long summarize their discussion of Inflammatory Bowel Disease (IBD) and discuss prospective advances in treatment options.
Latest:
Patient Education of HCMExpert cardiologists share strategies for educating patients on the treatment and management of hypertrophic cardiomyopathy.
Latest:
Resources for Patients and Providers on Adalimumab BiosimilarsExpert providers in inflammatory diseases provide additional resources on biosimilars and adalimumab biosimilar for patients and providers.
Latest:
Does Aggressive or Moderate Fluid Resuscitation Better Treat Acute Pancreatitis?A recent randomized controlled trial showed the limitations of either option, despite being a cornerstone of care.
Latest:
Managing Glaucoma During COVID-19: Patients Point the Way to Improved CareA new survey assessed patients’ confidence in their disease management during the pandemic, specific disease management concerns, and experiences with telemedicine.
Latest:
Cardiometabolic Medicine: Seeing the Patient as a WholeThe panelists stress the significance of a comprehensive approach to patient care, acknowledging the interconnected nature of cardiovascular, kidney, endocrine, and obesity-related benefits, and highlighting that addressing secondary diseases can minimize overall disease risk in patients.
Latest:
Coding for CKD DiagnosisPanelists discuss the key considerations for properly coding chronic kidney disease (CKD) diagnoses, with a particular focus on the nuances involved in coding for early-stage CKD.
Latest:
Fostering Next-Generation Expertise in Dry EyeExperts discuss strategies for making dry eye care an appealing practice option for optometry students and supporting their success in this specialized field.
Latest:
Esketamine Safety Mechanisms and BioavailabilityGeoffrey Grammer, MD closes this series highlighting the administration options of esketamine, its safety profile, and the importance of monitoring patients using this treatment.
Latest:
Optimizing Care for ADHD During COVID-19Optimizing care and managing challenges for patients with ADHD during the COVID-19 pandemic and advice for clinicians educating patients and families on disease management.
Latest:
Faricimab Versus High-Dose Aflibercept for the Treatment of Neovascular AMD and DMERetina specialists evaluate the effectiveness of the two new therapies for neovascular AMD and DME by analyzing their respective clinical trial methodologies and outcomes.
Latest:
Introducing the Concoff Method: The Interface Between Sports Medicine and RheumatologyIn today's issue of Rheumatology Network, we introduce The Concoff Method, a new column by Andrew Concoff, M.D., a rheumatologist who serves as executive vice president and chief value medical officer of United Rheumatology. Over the course of the next year, Dr. Concoff will publish columns that address sports medicine, value in rheumatology and managing a medical practice in the era of COVID-19. In this inaugural issue of the column, he covers the interface between sports medicine and rheumatology.
Latest:
Virginia Clark, MD: Understanding Fazirsiran’s Potential in AATD Liver DiseaseClark reviews open-label extension data from the phase 2b SEQUOIA study of fazirsiran for AATD liver disease.
Latest:
Selecting CD Treatment in Special ScenariosExperts in gastroenterology discuss treatment selection in special situations of CD, such as age, women considering pregnancy, and extra-intestinal manifestations.
Latest:
Final Thoughts on the Opioid Crisis and Normalizing NaloxoneThe multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.
Latest:
Dual-Orexin Receptor Antagonists for Treatment of InsomniaIn an upcoming Peer Exchange program entitled “Dual-Orexin Receptor Antagonists for Treatment of Insomnia” Dr Paul Doghramji will moderate a conversation with physicians about this class of agents for treatment of insomnia and discuss other therapeutic advancements in the field.
Latest:
Key Takeaways on the Evolving COPD Treatment LandscapeThe panel concludes the discussion with key takeaways on the evolving treatment landscape for COPD.
Latest:
Christian T. Ruff, MD, MPH: Abelacimab Cuts Bleeding Risk Versus RivaroxabanChristian. T. Ruff, MD, MPH describes an analysis of AZALEA-TIMI 71 demonstrating the substantial benefit of abelacimab on bleeding outcomes in patients on antiplatelet therapy.
Latest:
Patient-Specific Characteristics Driving AD Treatment RegimenDrs Keegan and Cameron discuss patient-specific considerations for selecting optimal atopic dermatitis treatment strategies.
Latest:
Practice Pearls for the Management of SCDA panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.
Latest:
Care Collaboration in Atopic DermatitisExperts in dermatology discuss patient education and clinical pearls to assist colleagues in the management of atopic dermatitis.
Latest:
Assessing the Draft Revised CDC Clinical Practice Guideline for Prescribing Opioids 2022The Director of Policy and Advocacy for the US Pain Foundation addresses the important changes made to the updated draft of the CDC Clinical Practical Guideline for Prescribing Opioids 2022.
Latest:
Switching Therapies in ADAndrew Blauvelt, MD, discusses switching therapies for atopic dermatitis (AD) treatment.
Latest:
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer SurvivorsDavidow discussed how a new cohort study has helped support findings of an older European study and the need for a prospective trial to confirm the increased risk.
